Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label European primary care study of pregabalin for chronic neuropathic low back pain
2010-022955-43Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pregabalin in Neuralgia and lumbodynia (LBP), sponsored by Pfizer. Primary endpoint: Change in daily pain diary mean pain score. Started Apr 2011; status: terminated.
02
Drugs
pregabalin
03
Conditions
Neuralgialumbodynia (LBP)
Beyond the preview
Go deeper on 2010-022955-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022955-43.